The past six months have been a windfall for Penumbra’s shareholders. The company’s stock price has jumped 55.5%, setting a ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Shares of medical device company Penumbra (NYSE:PEN) jumped 12.1% in the afternoon session after the company agreed to be ...

Alameda, CA-based Penumbra, Inc. PEN has secured the CE Mark in Europe for its newest computer-assisted vacuum thrombectomy (CAVT) technologies, Lightning Flash 2.0 and Lightning Bolt 7. Lightning ...

Penumbra is continuing to take share with its new CAVT devices against its closest competition in the VTE space. PEN reduced guidance after Q2 earnings, but the market took it in stride, with ...

Stocks edge up as Trump delays critical minerals tariffs and backs Powell; see top stock movers—Penumbra, Calix, Dell, Nokia, ...

Penumbra (NYSE:PEN) just reported results for the first quarter of 2024. Penumbra reported earnings per share of 41 cents. This was above the analyst estimate for EPS of 38 cents. The company reported ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth ...

Investors with an interest in Medical - Instruments stocks have likely encountered both Coloplast A/S Sponsored ADR (CLPBY) and Penumbra (PEN). But which of these two stocks offers value investors a ...